Genalyte

Primary contact

Genalyte completes a comprehensive battery of blood tests from a single drop of whole blood in the physician's office with results in 15 minutes. The company has built an advanced technology that uses silicon photonic biosensors and sends digital samples to the cloud for quality review before releasing to the physician and patient. Its central lab handles tests that cannot be completed onsite. Genalyte offers complete diagnostic services for a physician. Most common tests can be handled onsite, including chemistry, hematology, immunology, ESR, pathogen screening and urinalysis.
Primary contact

Funding 💰

Total $91.8M
Select investors Claremont Creek Ventures, Khosla Ventures, Redmile Group, BioMed Ventures, CLI Ventures
Last update: April 3, 2018